Cancer Family
Benign Nervous System Neoplasm
CI-CAN-00000084Explore in graph →
Non-malignant62 active trials2 evidence items
- NCIt
- C4789
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000084Explore in graph →
Clinical trials
232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05913037 | FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas | active not recruiting | Phase 3 | 167 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT06844461 | Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma(QOL-DR-NEUROMA) | recruiting | — | 40 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER |
| 1 |
| Feb 25, 2025 |
| clinicaltrials |
| NCT04730583 | Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05641441 | Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma | recruiting | — | 258 | University Hospital, GenevaOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT05254197 | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)(SOLOMON) | recruiting | — | 3,000 | Seoul National University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT04648462 | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | recruiting | — | 1,500 | Maastricht Radiation OncologyOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT03745534 | Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study | recruiting | — | 8 | Christoph ArnoldnerOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT03745560 | Intraoperative EABR for Decision Making | recruiting | — | 15 | Christoph ArnoldnerOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT04954001 | Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 | active not recruiting | Phase 1 / Phase 2 | 160 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 3 | Nov 12, 2024 | clinicaltrials |
| NCT03346889 | Vestibular Outcomes in Vestibular Schwannoma(VOVS) | active not recruiting | — | 155 | Haukeland University HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06616909 | Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences | active not recruiting | N/A | 120 | National Taiwan University HospitalOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06112509 | Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery(EVERS) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06572475 | USPIO Enhanced MR Imaging in CNS Tumours (UMIC)(UMIC) | recruiting | N/A | 17 | Northern Care Alliance NHS Foundation TrustOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT03531814 | Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials | completed | N/A | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06296732 | Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification(ANLAP-R) | recruiting | — | 200 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06421805 | Establishing Prospective Mediastinal Tumor Database of PUMCH(MTDPUMCH) | recruiting | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT05438290 | DPCP to Treat Cutaneous Neurofibromas Associated With NF1 | completed | Phase 1 | 17 | Nicholas GulatiOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT04241679 | Auditory Nerve Test System During Vestibular Schwannoma Resection(ANTS) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06379230 | A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE) | unknown | — | 2,000 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT05518942 | Effects of SMR Neurofeedback on Insomnia in Patients With Benign Brain Tumors | terminated | N/A | 5 | Taipei Medical UniversityOTHER | 1 | Apr 22, 2024 | clinicaltrials |
| NCT01938677 | Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study | completed | N/A | 67 | Karolinska InstitutetOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT03741101 | Treatment of NF1-related Plexiform Neurofibroma With Trametinib(plexifpc) | unknown | Phase 2 | 15 | Region SkaneOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT03326388 | Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours(INSPECT) | completed | Phase 1 / Phase 2 | 14 | Great Ormond Street Hospital for Children NHS Foundation TrustOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT04163419 | Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | unknown | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04158284 | Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts | unknown | — | 90 | Klinikum Oldenburg gGmbHOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT05525273 | Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma(Swecranio) | recruiting | Phase 2 | 25 | Eva Marie Erfurth, MD, PhDOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT01345136 | Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma | terminated | Phase 2 | 4 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05199376 | Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1(CryoNF1) | recruiting | N/A | 30 | Centre Leon BerardOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT02842723 | Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma) | completed | Phase 2 | 33 | Institut CurieOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06217848 | The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study | unknown | Early Phase 1 | 50 | Seoul National University HospitalOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04851925 | MR Fingerprinting for Vestibular Schwannomas | unknown | — | 50 | Medical University of ViennaOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT02839720 | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Dec 6, 2023 | clinicaltrials |
| NCT00019578 | Stereotactic Radiosurgery in Treating Patients With Brain Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04801953 | Nimodipine in Vestibular Schwanommas | unknown | Phase 2 | 30 | Medical University of ViennaOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT05116878 | Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma(EFFORTS) | terminated | N/A | 15 | Mayo ClinicOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT01885767 | Neurofibromatosis (NF) Registry Portal | recruiting | — | 20,000 | The Children's Tumor FoundationOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT04351373 | Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 | completed | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT03581331 | Consequence of Unilateral Vestibular Loss on Visual Abilities(SVorthoptie) | completed | N/A | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT04712214 | Use of Non-invasive Optical Analysis in Neurosurgery | unknown | N/A | 50 | Imperial College LondonOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT03958006 | Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma | completed | N/A | 6 | Henry Ford Health SystemOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT04890132 | Vestibular Precision: Physiology & Pathophysiology | unknown | N/A | 90 | Massachusetts Eye and Ear InfirmaryOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT04584086 | Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received(BRAIN TEL) | completed | N/A | 20 | Centre Francois BaclesseOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03542773 | Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET | completed | Phase 1 | 38 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT03666507 | Vegetative Monitoring During Brainstem-associated Surgery | completed | — | 103 | University Hospital TuebingenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT02849743 | Intranasal Oxytocin in Hypothalamic Obesity | completed | Phase 2 | 18 | Shana McCormack, MDOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT05567341 | Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery(RIC-VS) | unknown | N/A | 120 | University Hospital TuebingenOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT04658836 | Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF | completed | Phase 1 | 21 | Medical University of ViennaOTHER | 1 | Aug 24, 2022 | clinicaltrials |
| NCT04435665 | NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) | completed | Phase 2 | 48 | NFlection Therapeutics, Inc.INDUSTRY | 1 | Aug 9, 2022 | clinicaltrials |
| NCT01129687 | Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy | completed | — | 157 | Stanford UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT03057678 | Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery(PPF) | withdrawn | N/A | 0 | Vanderbilt University Medical CenterOTHER | 1 | Jan 20, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Mar 6, 2025source: clinicaltrials